UBC in the News: Meeting the Challenges of Market Access in the Specialty Drug Market

Market access for specialty drugs

UBC in the News: Meeting the Challenges of Market Access in the Specialty Drug Market

According to Express Scripts 2015 Drug Trend Report, despite being used by only 1-2% of the population, specialty medications accounted for 37% of U.S. drug spend in 2015 and are projected to reach 50% by 2018. As the specialty market continues to grow, so do the market access challenges associated with these products requiring high-touch services. In the latest edition of PharmaVoice, UBC’s Vice President of Patient Access & Engagement, Nicole Hebbert, discusses how these market access challenges have forced pharmaceutical manufacturers to reevaluate their approach when it comes to commercializing their specialty medications.  

Click here to read the article.